Incidence of hyperthyroidism in Sweden

European Journal of Endocrinology

Volumn 165, Issue 6, 2011, Pages 899-905

  Abraham Nordling, Mirna ^a   Byström, Kristina ^b   Törring, Ove ^c   Lantz, Mikael ^d   Berg, Gertrud ^e   Calissendorff, Jan ^c   Nyström, Helena Filipsson ^f   Jansson, Svante ^f   Jörneskog, Gun ^a   Karlsson, Fanders ^g   Nyström, Ernst ^f   Ohrling, Hans ^c   Örn, Thomas ^h   Hallengren, Bengt ^d   Wallin, Göran ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h BLEKINGE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; INCIDENCE; INFANT; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SWEDEN; THYROID ADENOMA; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TOXIC GOITER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; HYPERTHYROIDISM; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SWEDEN; YOUNG ADULT;

EID: 81555222784     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0548     Document Type: Article

References (36)

1. Laurberg P, Bulow Pedersen I, Pedersen KM & Vestergaard H. Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake. Thyroid 1999 9 33-38. (doi:10.1089/thy.1999. 9.33)
2. Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, Pedersen IB & Carle A. Iodine intake as a determinant of thyroid disorders in populations. Best Practice and Research. Clinical Endocrinology and Metabolism 2010 24 13-27. (doi:10. 1016/j.beem.2009.08.013)
3. Carle A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen L & Laurberg P. Epidemiology of subtypes of hyperthyroidism in Denmark - a population-based study. European Journal of Endocrinology 2011 164 801-809. (doi:10.1530/EJE- 10-1155)
4. Berglund J, Christensen SB & Hallengren B. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmo 1970-74. Journal of Internal Medicine 1990 227 137-141. (doi:10.1111/j.1365-2796.1990. tb00132.x)
5. Berglund J, Ericsson UB & Hallengren B. Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974. Journal of Internal Medicine 1996 239 57-62. (doi:10.1046/j.1365- 2796.1996. 415757000.x)
6. Lundgren E & Borup Christensen S. Decreasing incidence of thyrotoxicosis in an endemic goitre inland area of Sweden. Clinical Endocrinology 1990 33 133-138. (doi:10.1111/j.1365-2265. 1990.tb00473.x)
7. Haraldsson A, Gudmundsson ST, Larusson G & Sigurdsson G. Thyrotoxicosis in Iceland 1980-1982. An epidemiological survey. Acta Medica Scandinavica 1985 217 253-258. (doi:10.1111/j. 0954-6820.1985.tb02691.x)
8. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F & Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology 1995 43 55-68. (doi:10.1111/j. 1365-2265.1995.tb01894.x)
9. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L & Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. European Journal of Endocrinology 2000 143 485-491. (doi:10.1530/eje.0.1430485)
10. Brownlie BE &Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in North Canterbury, 1983-1985. Clinical Endocrinology 1990 33 249-259. (doi:10.1111/j.1365-2265.1990.tb00489. x)
11. Leese GP, Flynn RV, Jung RT, Macdonald TM, Murphy MJ & Morris AD. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clinical Endocrinology 2008 68 311-316. (doi:10.1111/j.1365-2265.2007.03051.x)
12. Laurberg P, Bulow Pedersen I, Knudsen N, Ovesen L & Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid 2001 11 457-469. (doi:10.1089/ 105072501300176417)
13. Connolly RJ. An increase in thyrotoxicosis in southern Tasmania after an increase in dietary iodine. Medical Journal of Australia 1971 1 1268-1271.
14. Bulow Pedersen I, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L & Rasmussen LB. Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark. Journal of Clinical Endocrinology and Metabolism 2006 91 3830-3834. (doi:10.1210/jc.2006- 0652)
15. Abraham-Nordling M, Torring O, Lantz M, Hallengren B, Ohrling H, Lundell G, Calissendorff J, Jorneskog G & Wallin G. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. European Journal of Endocrinology 2008 158 823-827. (doi:10. 1530/EJE-07-0877)
16. Lantz M, Abraham-Nordling M, Svensson J, Wallin G & Hallengren B. Immigration and the incidence of Graves'thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma. European Journal of Endocrinology 2009 160 201-206. (doi:10.1530/EJE-08-0548)
17. McGrogan A, Seaman HE,Wright JW & de Vries CS. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clinical Endocrinology 2008 69 687-696. (doi:10. 1111/j.1365-2265.2008.03338.x)
18. Weetman AP. Graves' disease. New England Journal of Medicine 2000 343 1236-1248. (doi:10.1056/NEJM20001026343 1707)
19. Franklyn J. Thyrotoxicosis. Clinical Medicine 2003 3 11-15.
20. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T & Smith PA. The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology 1977 7 481-493. (doi:10.1111/j.1365-2265. 1977.tb01340.x)
21. Andersson M, Berg G, Eggertsen R, Filipsson H, Gramatkovski E, Hansson M, Hulthen L, MilakovicM& Nystrom E. Adequate iodine nutrition in Sweden: a cross-sectional national study of urinary iodine concentration in school-age children. European Journal of Nutrition 2009 63 828-834. (doi:10.1038/ejcn.2008. 46)
22. Filipsson Nystrom H, Andersson M, Berg G, Eggertsen R, Gramatkowski E, Hansson M, Hulthen L, Milakovic M & Nystrom E. Thyroid volume in Swedish school children: a national, stratified, population-based survey. European Journal of Nutrition 2010 64 1289-1295. (doi:10.1038/ejcn.2010.162)
23. Roti E & Degli Uberti E. Iodine excess and hyperthyroidism. Thyroid 2001 11 493-500. (doi:10.1089/105072501300176453)
24. Cooper DS. Hyperthyroidism. Lancet 2003 362 459-468. (doi:10. 1016/S0140-6736(03)14073-1)
25. Laurberg P, Andersen S, Pedersen IB, Ovesen L & Knudsen N. Humic substances in drinking water and the epidemiology of thyroid disease. Biofactors 2003 19 145-153. (doi:10.1002/biof. 5520190307)
26. Flynn RW, MacDonald TM, Morris AD, Jung RT & Leese GP. The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. Journal of Clinical Endocrinology and Metabolism 2004 89 3879-3884. (doi:10.1210/jc.2003- 032089)
27. Hagg E & Asplund K. Is endocrine ophthalmopathy related to smoking? British Medical Journal 1987 295 634-635. (doi:10. 1136/bmj.295.6599.634)
28. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall- Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Curro N, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marino M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G & Wiersinga WM.Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 2008 18 333-346. (doi:10.1089/thy.2007.0315)
29. Traisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nystrom E, Ponjavic V, Taube A, Torring O, Wallin G, Asman P & Lundell G. Thyroid-associated ophthalmopathy after treatment for Graves'hyperthyroidism with antithyroid drugs or iodine-131. Journal of Clinical Endocrinology and Metabolism 2009 94 3700-3707. (doi:10.1210/jc.2009-0747)
30. Phillips DI, Barker DJ & Morris JA. Seasonality of thyrotoxicosis. Journal of Epidemiology and Community Health 1985 39 72-74. (doi:10.1136/jech. 39.1.72)
31. Buchinger W, Semlitsch G, Pongratz R, Harwalik B & Rainer F. Seasonal variations in the diagnosis of hyperthyroidism. Acta Medica Austriaca 2000 27 51-53. (doi:10.1046/j.1563-2571. 2000.00206.x)
32. Ford HC, Johnson LA, Feek CM & Newton JD. Iodine intake and the seasonal incidence of thyrotoxicosis in New Zealand. Clinical Endocrinology 1991 34 179-181. (doi:10.1111/j.1365-2265. 1991.tb00290.x)
33. Westphal SA. Seasonal variation in the diagnosis of Graves'disease. Clinical Endocrinology 1994 41 27-30. (doi:10.1111/j. 1365-2265.1994.tb03780.x)
34. Velentzas C, Oreopoulos DG, From G, Porret B & Rapopart A. Vitamin-D levels in thyrotoxicosis. Lancet 1977 1 370-371. (doi:10.1016/S0140-6736(77) 91177-1)
35. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281. (doi:10.1056/NEJMra070553)
36. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA & Stan MN. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011 21 593-646. (doi:10.1089/thy. 2010.0417)